Monday April 19, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

July 2006

Rapid Development of High Productivity Fed-Batch Cell Culture Processes Using a Platform Approach

by BPI Contributor
Add Comment
July 1, 2006

Cryopreservation, Storage, and Transportation of Biological Process Intermediates

by BPI Contributor
Add Comment
July 1, 2006

Offering Downstream Processing Equipment, Systems, and R& D Studies from Laboratory to Industrial Scale

by BPI Contributor
Add Comment
July 1, 2006

Robust Small Virus Removal with Planova® Virus-Removal Filters: No Effect from Varying Virus-Spike Quality and Concentration in a Validation Model

by BPI Contributor
Add Comment
July 1, 2006

OPULUS Provides New, Real-Time Measurement System for Moisture Permeability and Packaging Validation

by BPI Contributor
Add Comment
July 1, 2006

DAISOGEL C4-Modified Phases for Protein Purification

by BPI Contributor
Add Comment
July 1, 2006

NCSRT: Breaking the Downstream Bottleneck

by BPI Contributor
Add Comment
July 1, 2006

Strategic Collaboration: Products and Services Designed to Facilitate Culture Media Development

by BPI Contributor
Add Comment
July 1, 2006

Octet System: Label-Free, Real-Time Kinetic Analysis for Bioprocessing

by BPI Contributor
Add Comment
July 1, 2006

CGMP Custom Manufacturing of Tomorrow’s Medicines

by BPI Contributor
Add Comment
July 1, 2006
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • >

Editor’s Choice

  • BioProcess Insider

    Resilience adds CDMO Ology to growing manufacturing footprint

  • BioProcess Insider

    Horseshoe crabs: COVID-19 further threat to ‘blue blood’ of industry

  • Sponsored Content

    Rapid Development of Viral Vector Production Processes: Iterative Parameter Optimization

  • BioProcess Insider

    BARDA to give Emergent another $23m for tech after J&J jab mix-up

  • BioProcess Insider

    Sanofi to build $700m Canadian flu vaccine plant

  • Sponsored Content

    Ask the Expert: Leveraging Cloud Capabilities to Execute CHO Cell Culture Experiments

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: In the latest example of pandemic-related collaboration, @Novartis is prepping to make the drug substance for Roche… https://t.co/IpIbSP7F1c 3 days ago
  • Tweet Avatar RT @Dan5tanton: As part of a “difficult decision” to halt its biosimilars programs in China, Pfizer is offloading its single-use bi… https://t.co/vsE7WAknKd 1 month ago
  • Tweet Avatar RT @Dan5tanton: Thermo Fisher’s $600 million CAPEX has got the trade press salivating. But similar statements, expansions underway,… https://t.co/5xHNdfJwRw 1 month ago
  • Tweet Avatar RT @Dan5tanton: Calls for standardization to boost manufacturing agility by executives from Novavax, Fujifilm, and Biocon after a C… https://t.co/UJO2CH09K8 2 months ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Lifecycle approach could cut cell and gene therapy costs

  • BioProcess Insider

    WuXi Bio set for 430,000 L biomanufacturing capacity from 2024

  • BioProcess Insider

    Oravax launches to advance oral COVID-19 vaccines

  • BioProcess Insider

    Novartis exiting Longmont due to changing gene therapy capacity need

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events